study results for nivolumab and pembrolizumab in head and neck cancer
Published 7 years ago • 374 plays • Length 2:07Download video MP4
Download video MP3
Similar videos
-
4:03
keynote-040: groundbreaking results for pembrolizumab in head and neck cancer
-
1:00
dr. ferris on pembrolizumab and nivolumab in head and neck cancer
-
0:40
dr. vokes on selecting nivolumab or pembrolizumab for head and neck cancer treatment
-
1:58
dr. vokes on nivolumab, pembrolizumab approvals in head and neck cancer
-
6:51
pembrolizumab and nivolumab in recurrent hnscc
-
1:19
five-year follow-up results for nivolumab in nsclc
-
26:30
head and neck cancer treatment update: pembrolizumab, nivolumab and pd-l1 markers
-
0:54
dr. robert ferris on a phase iii study regarding nivolumab in head and neck cancer
-
7:03
pembrolizumab for frontline head and neck cancer: keynote-048 results
-
2:45
final keynote-048 results with frontline pembrolizumab in recurrent/metastatic hnscc
-
6:17
pembrolizumab for head and neck cancer
-
1:34
dr. ferris discusses nivolumab in head and neck cancer
-
2:13
nivolumab in hnscc
-
1:36
addition of an egfr/tgfβ inhibitor with pembrolizumab in head and neck cancer
-
1:36
dr. ferris on potential of nivolumab in head and neck cancer
-
4:06
immunotherapy for head and neck cancer treatment
-
1:36
dr. seiwert on prognosis for patients with head and neck cancer
-
4:11
data from keynote 12 - nivolumab and pembrolizumab
-
17:30
immunotherapy in lung cancer: panacea vs. reality?